Lantheus Holdings (LNTH) Interest & Investment Income (2024 - 2026)
Lantheus Holdings (LNTH) posted quarterly Interest & Investment Income of $5.0 million for Q1 2026, down 47.6% year-over-year from $9.5 million in Q1 2025, and up 61.7% quarter-over-quarter from $3.1 million in Q4 2025.
Lantheus Holdings (LNTH) Interest & Investment Income (2024 - 2026) Analysis & Trends
Lantheus Holdings (LNTH) has reported Interest & Investment Income for 3 consecutive years, with $5.0 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Interest & Investment Income fell 47.6% year-over-year to $5.0 million; the TTM figure through Mar 2026 stood at $18.9 million (down 50.02% YoY), while the FY2025 annual figure was $23.4 million, down 36.5% from the prior year.
- Interest & Investment Income grew to $5.0 million in Q1 2026 per LNTH's latest filing, from $3.1 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $9.8 million in Q3 2024 and bottomed at $3.1 million in Q4 2025.
- Historically, Interest & Investment Income has averaged $7.1 million across 3 years, with a median of $8.1 million in 2024.
- On a YoY basis, Interest & Investment Income climbed as much as 19.17% in 2025 and fell as far as 67.87% in 2025.
- Lantheus Holdings' Interest & Investment Income stood at $9.6 million in 2024, then plunged by 67.87% to $3.1 million in 2025, then surged by 61.7% to $5.0 million in 2026.
- Business Quant data shows LNTH's Interest & Investment Income at $5.0 million in Q1 2026, $3.1 million in Q4 2025, and $3.6 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.91 Bn | 42.95 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.15 Bn | 39.49 Bn | 2.15 Bn | - |
| 3 | Zoetis | 31.52 Bn | 29.84 Bn | 1.05 Bn | - |
| 4 | Takeda Pharmaceutical | 28.58 Bn | 22.78 Bn | 5.10 Bn | 154.39 Mn |
| 5 | United Therapeutics | 22.16 Bn | 19.50 Bn | 683.80 Mn | 31.50 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | - |
| 7 | Neurocrine Biosciences | 15.48 Bn | 15.09 Bn | 935.80 Mn | 12.40 Mn |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | Lantheus Holdings | 6.52 Bn | 5.93 Bn | 241.86 Mn | 6.26 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 6.26 Mn |
| Mar 31, 2026 | 4.97 Mn |
| Dec 31, 2025 | 3.07 Mn |
| Sep 30, 2025 | 3.62 Mn |
| Jun 30, 2025 | 7.21 Mn |
| Mar 31, 2025 | 9.48 Mn |
| Dec 31, 2024 | 9.57 Mn |
| Sep 30, 2024 | 9.80 Mn |
| Jun 30, 2024 | 8.92 Mn |